A Study to Access the Safety and Efficacy of CT0590 in Patients With Relapsed and/or Refractory Multiple Myeloma

NCT05066022 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Relapsed and/or Refractory Multiple Myeloma

Interventions

BIOLOGICAL: CT0590 CAR T Cells

Sponsor

The First Affiliated Hospital of Soochow University

Collaborators

[object Object]